Tariff Trap: How Trump's Plan Will Inflate Generic Drug Prices The proposed tariffs on generic drugs announced by President Donald Trump have sparked a warning from Erez Israeli, CEO of Dr.
Reddy's Laboratories, one of India's leading pharmaceutical firms.
The levies, set to kick in at 100% in August 2028 and rise to 200% a year later, are intended to "onshore" the generic medicine industry to the United States.